MRI contrast medium injection system, line-powered, stationary
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Guerbet Australia Pty Ltd
Class:
Class I
Manufactured by:
Liebel-Flarsheim Company LLC 2111 East Galbraith Road, Cincinnati, Ohio, 45237-1640 United States Of America
Therapeutic area:
58002 - MRI contrast medium injection system, line-powered, stationary
Therapeutic indications:
Accessory components to be used with the Optistar Elite contrast delivery system.
Authorization status:
A
Authorization date:
2019-04-11
